PMID- 31721400 OWN - NLM STAT- MEDLINE DCOM- 20210514 LR - 20210514 IS - 1445-2197 (Electronic) IS - 1445-1433 (Linking) VI - 90 IP - 4 DP - 2020 Apr TI - Minimally invasive major hepatectomies: a Southeast Asian single institution contemporary experience with its first 120 consecutive cases. PG - 553-557 LID - 10.1111/ans.15563 [doi] AB - BACKGROUND: The role of minimally invasive major hepatectomy (MIMH) remains controversial and questions remain about its safety and reproducibility outside expert centres. This study examines the changing trends, safety and outcomes associated with the adoption of MIMH based on a contemporary single institution experience. METHODS: This study is a review of 120 consecutive patients who underwent MIMH between 2011 and 2018. To determine the evolution of MIMH, the study population was stratified into four equal groups of patients. Both conventional major hepatectomies (CMHs) (>/=3 segments) and technical major hepatectomies (right anterior and posterior sectionectomies) were included. RESULTS: There were 70 CMHs and 50 technical major hepatectomies. Seven MIMHs were laparoscopic-assisted and 113 (94.2%) were totally laparoscopic/robotic. There were 10 (8.3%) open conversions. Comparison across the four groups demonstrated that with increasing experience, there was a significant trend in a higher proportion of higher American Society of Anesthesiologists score patients, increasing frequency of CMH performed, increasing frequency of multifocal tumours resected, decreasing use of laparoscopic-assisted approach and decrease in blood loss. CONCLUSION: MIMH can be adopted safely today with a low open conversion rate. Over time with increasing experience, we performed MIMH with increasing frequency in higher risk patients and in patients with multifocal tumours but with a decrease in median estimated blood loss. CI - (c) 2019 Royal Australasian College of Surgeons. FAU - Goh, Brian K P AU - Goh BKP AUID- ORCID: 0000-0001-8218-4576 AD - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore. AD - Office of Clinical Sciences, Duke-NUS Medical School, Singapore. FAU - Lee, Ser-Yee AU - Lee SY AD - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore. AD - Office of Clinical Sciences, Duke-NUS Medical School, Singapore. FAU - Koh, Ye-Xin AU - Koh YX AD - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore. AD - Office of Clinical Sciences, Duke-NUS Medical School, Singapore. FAU - Kam, Juinn-Huar AU - Kam JH AD - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore. FAU - Chan, Chung-Yip AU - Chan CY AD - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore. AD - Office of Clinical Sciences, Duke-NUS Medical School, Singapore. LA - eng PT - Journal Article PT - Review DEP - 20191112 PL - Australia TA - ANZ J Surg JT - ANZ journal of surgery JID - 101086634 SB - IM MH - Hepatectomy MH - Humans MH - *Laparoscopy MH - Length of Stay MH - *Liver Neoplasms/surgery MH - Reproducibility of Results MH - Retrospective Studies MH - Treatment Outcome OTO - NOTNLM OT - laparoscopic hepatectomy OT - laparoscopic liver OT - major hepatectomy OT - minimally invasive hepatectomy OT - robotic hepatectomy EDAT- 2019/11/14 06:00 MHDA- 2021/05/15 06:00 CRDT- 2019/11/14 06:00 PHST- 2019/09/07 00:00 [received] PHST- 2019/10/12 00:00 [revised] PHST- 2019/10/14 00:00 [accepted] PHST- 2019/11/14 06:00 [pubmed] PHST- 2021/05/15 06:00 [medline] PHST- 2019/11/14 06:00 [entrez] AID - 10.1111/ans.15563 [doi] PST - ppublish SO - ANZ J Surg. 2020 Apr;90(4):553-557. doi: 10.1111/ans.15563. Epub 2019 Nov 12.